Docoh
Loading...

ISEE IVERIC bio

News

Pro users get this 30m faster
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
28 Sep 21
Biotech, News, Penny Stocks, Small Cap, FDA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27)
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
22 Sep 21
Biotech, News, Penny Stocks, Guidance, Offerings, Small Cap, FDA, Legal, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20)
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
16 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15)
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
15 Sep 21
Biotech, News, Penny Stocks, Offerings, Small Cap, FDA, IPOs, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14)
60 Biggest Movers From Friday
13 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers
Mid-Afternoon Market Update: Dow Slides Over 100 Points; Echo Global Logistics Shares Spike Higher
10 Sep 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Toward the end of trading Friday, the Dow traded down 0.31% to 34,772.74 while the NASDAQ fell 0.27% to 15,207.42. The S&P also fell, dropping 0.28% to 4,480.86.
8 Health Care Stocks With Unusual Options Alerts In Today's Session
10 Sep 21
Options
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.
12 Health Care Stocks Moving In Friday's Intraday Session
10 Sep 21
Intraday Update, Markets, Movers
Mid-Day Market Update: Crude Oil Rises Over 2%; Apellis Pharmaceuticals Shares Plunge
10 Sep 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Midway through trading Friday, the Dow traded down 0.40% to 34,739.37 while the NASDAQ fell 0.06% to 15,238.92. The S&P also fell, dropping 0.21% to 4,483.84.
41 Stocks Moving In Friday's Mid-Day Session
10 Sep 21
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
Why IVERIC Bio Shares Are Soaring Today
10 Sep 21
News, Price Target, Initiation, Small Cap, Analyst Ratings
IVERIC Bio Inc (NASDAQ: ISEE) is trading significantly higher Friday after Apellis Pharmaceuticals Inc (NASDAQ: APLS) reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy.
Mid-Morning Market Update: Markets Mixed; Kroger Tops Q2 Views
10 Sep 21
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
Following the market opening Friday, the Dow traded down 0.15% to 34,827.04 while the NASDAQ rose 0.32% to 15,296.61. The S&P also rose, gaining 0.03% to 4,494.53.
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
10 Sep 21
Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings
Credit Suisse Maintains Outperform on IVERIC bio, Raises Price Target to $18
10 Sep 21
News, Price Target, Analyst Ratings
Credit Suisse analyst Tiago Fauth maintains IVERIC bio (NASDAQ:ISEE) with a Outperform and raises the price target from $15 to $18.
12 Health Care Stocks Moving In Friday's Pre-Market Session
10 Sep 21
Pre-Market Outlook, Markets, Movers
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
10 Sep 21
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9)
Why Are Iveric Bio Shares Surging In Premarket Friday?
10 Sep 21
Analyst Color, Biotech, Long Ideas, News, Health Care, Price Target, Initiation, Small Cap, Analyst Ratings, Movers, Trading Ideas, General
20 Stocks Moving in Friday's Pre-Market Session
10 Sep 21
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers IVERIC bio, Inc. (NASDAQ: ISEE) rose 29.6% to $11.26 in pre-market trading. Iveric Bio recently reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
Stifel Initiates Coverage On IVERIC bio with Buy Rating, Announces Price Target of $22
10 Sep 21
News, Price Target, Initiation, Analyst Ratings
Stifel analyst Annabel Samimy initiates coverage on IVERIC bio (NASDAQ:ISEE) with a Buy rating and announces Price Target of $22.
12 Health Care Stocks Moving In Thursday's After-Market Session
9 Sep 21
Movers
Gainers

Press releases

Pro users get this 30m faster
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Oct 21
Press Releases
IVERIC bio, Inc. (NASDAQ:ISEE) today reported that on October 1, 2021, the Company granted equity-based awards pursuant to the Company's 2019 Inducement Stock Incentive Plan to eight newly-hired, non-executive
Iveric Bio to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
10 Sep 21
Press Releases
IVERIC bio, Inc. (NASDAQ:ISEE) announced today that Pravin U. Dugel, M.D., President, will present an overview of the Company at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually from
Thinking about buying stock in IVERIC bio, T2 Biosystems, Endo International, Arbutus Biopharma, or Katapult?
10 Sep 21
Opinion, Press Releases
NEW YORK, Sept. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ISEE, TTOO, ENDP, ABUS, and KPLT.
Iveric Bio Reports Second Quarter 2021 Operational Highlights and Financial Results
4 Aug 21
Press Releases
- FDA Agreement Under Special Protocol Assessment (SPA) Received for GATHER2 Phase 3 Clinical Trial of Zimura® in Geographic Atrophy Secondary to Age-Related Macular Degeneration – - Zimura GATHER2 Enrollment
Iveric Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
3 Aug 21
Press Releases
IVERIC bio, Inc. (NASDAQ:ISEE) today reported that on August 2, 2021, the Company granted equity-based awards pursuant to the Company's 2019 Inducement Stock Incentive Plan to five newly hired employees. The inducement
Iveric Bio Completes Patient Enrollment of GATHER2 Pivotal Clinical Trial of Zimura® Ahead of Schedule
26 Jul 21
Press Releases
- Topline Data Expected in 2H 2022; if Positive, New Drug Application Expected - IVERIC bio, Inc. (NASDAQ:ISEE) today announced the early completion of patient enrollment of GATHER2, the Company's second pivotal
Iveric Bio Appoints Christopher Simms as Chief Commercial Officer
19 Jul 21
Press Releases
– Former U.S. Franchise Head of Ophthalmics at Novartis Brings a Proven Track Record in Major Retinal Product Launches – IVERIC bio, Inc. (NASDAQ:ISEE) announced today the appointment of Christopher Simms to Senior